Cargando…
Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment
Autores principales: | Gavriel, Yuval, Rabinovich-Nikitin, Inna, Solomon, Beka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451578/ https://www.ncbi.nlm.nih.gov/pubmed/34100443 http://dx.doi.org/10.4103/1673-5374.314303 |
Ejemplares similares
-
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2012) -
Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2016) -
Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS
por: Rabinovich-Toidman, Polina, et al.
Publicado: (2015) -
CXCR4/CXCL12 expression and signalling in kidney cancer
por: Schrader, A J, et al.
Publicado: (2002) -
CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)